Stroke unit admission is associated with better outcome and lower mortality in patients with intracerebral hemorrhage.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
05 2020
Historique:
received: 03 11 2019
accepted: 03 02 2020
pubmed: 7 2 2020
medline: 22 6 2021
entrez: 7 2 2020
Statut: ppublish

Résumé

There is no clear consensus among current guidelines on the preferred admission ward [i.e. intensive care unit (ICU) or stroke unit (SU)] for patients with intracerebral hemorrhage. Based on expert opinion, the American Heart Association and European Stroke Organization recommend treatment in neurological/neuroscience ICUs (NICUs) or SUs. The European Stroke Organization guideline states that there are no studies available directly comparing outcomes between ICUs and SUs. We performed an observational study comparing outcomes of 10 811 consecutive non-comatose patients with intracerebral hemorrhage according to admission ward [ICUs, SUs and normal wards (NWs)]. Primary outcomes were the modified Rankin Scale score at discharge and intrahospital mortality. An additional analysis compared NICUs with SUs. Treatment outside an SU was associated with higher odds for an unfavorable outcome [ICU vs. SU: odds ratio (OR), 1.27; 95% confidence interval (CI), 1.09-1.46; NW vs. SU: OR, 1.28; 95% CI, 1.08-1.52] and higher odds for intrahospital mortality (ICU vs. SU: OR, 2.11; 95% CI, 1.75-2.55; NW vs. SU: OR, 1.52; 95% CI, 1.23-1.89). A subgroup analysis of severely affected patients treated in dedicated NICUs (vs. SUs) showed that they had a lower risk of a poor outcome (OR, 0.45; 95% CI, 0.26-0.79). Treatment in SUs was associated with better functional outcome and reduced mortality compared with ICUs and NWs. Our findings support the current guideline recommendations to treat patients with intracerebral hemorrhage in SUs or NICUs and suggest that some patients may further benefit from NICU treatment.

Sections du résumé

BACKGROUND AND PURPOSE
There is no clear consensus among current guidelines on the preferred admission ward [i.e. intensive care unit (ICU) or stroke unit (SU)] for patients with intracerebral hemorrhage. Based on expert opinion, the American Heart Association and European Stroke Organization recommend treatment in neurological/neuroscience ICUs (NICUs) or SUs. The European Stroke Organization guideline states that there are no studies available directly comparing outcomes between ICUs and SUs.
METHODS
We performed an observational study comparing outcomes of 10 811 consecutive non-comatose patients with intracerebral hemorrhage according to admission ward [ICUs, SUs and normal wards (NWs)]. Primary outcomes were the modified Rankin Scale score at discharge and intrahospital mortality. An additional analysis compared NICUs with SUs.
RESULTS
Treatment outside an SU was associated with higher odds for an unfavorable outcome [ICU vs. SU: odds ratio (OR), 1.27; 95% confidence interval (CI), 1.09-1.46; NW vs. SU: OR, 1.28; 95% CI, 1.08-1.52] and higher odds for intrahospital mortality (ICU vs. SU: OR, 2.11; 95% CI, 1.75-2.55; NW vs. SU: OR, 1.52; 95% CI, 1.23-1.89). A subgroup analysis of severely affected patients treated in dedicated NICUs (vs. SUs) showed that they had a lower risk of a poor outcome (OR, 0.45; 95% CI, 0.26-0.79).
CONCLUSIONS
Treatment in SUs was associated with better functional outcome and reduced mortality compared with ICUs and NWs. Our findings support the current guideline recommendations to treat patients with intracerebral hemorrhage in SUs or NICUs and suggest that some patients may further benefit from NICU treatment.

Identifiants

pubmed: 32026543
doi: 10.1111/ene.14164
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-832

Investigateurs

Martin Schabet (M)
Karin Schoser (K)
Michael Daffertshofer (M)
Stephan Neumaier (S)
Rita Sorge (R)
Elke Drewitz (E)
Sonja Hyrenbach (S)

Informations de copyright

© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Van Valburg MK, Sesmu Arbous M, Georgieva M, Brealey DA, Singer M, Geerts BF. Clinical predictors of survival and functional outcome of stroke patients admitted to critical care. Crit Care Med 2018; 46: 1085-1092.
Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9: 840-855.
Shen Y, Chao BH, Cao L, Tu WJ, De Wang L. Stroke center care and outcome: results from the CSPPC stroke program. Transl Stroke Res 2019. https://doi.org/10.1007/s12975-019-00727-6
Cadilhac DA, Grimley R, Kilkenny MF, et al. Multicenter, prospective, controlled, before-and-after, quality improvement study (Stroke123) of acute stroke care. Stroke 2019; 50: 1525-1530.
Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46: 2032-2060.
Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29: 635-640.
Gumbinger C, Reuter B, Wiethölter H, et al. A consecutive and prospective stroke database covers the state of Baden-Wuerttemberg with 10.8 million inhabitants in Germany. Neuroepidemiology 2013; 41: 161-168.
Gensicke H, Strbian D, Zinkstok SM, et al. Intravenous thrombolysis in patients dependent on the daily help of others before stroke. Stroke 2016; 47: 450-456.
Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 2017; 389: 603-611.
Fehnel CR, Glerum KM, Wendell LC, et al. Safety and costs of stroke unit admission for select acute intracerebral hemorrhage patients. Neurohospitalist 2018; 8: 12-17.
Ward MJ, Shutter LA, Branas CC, Adeoye O, Albright KC, Carr BG. Geographic access to US Neurocritical Care Units registered with the Neurocritical Care Society. Neurocrit Care 2012; 16: 232-240.
Jeong J-H, Bang J, Jeong W, et al. A dedicated neurological intensive care unit offers improved outcomes for patients with brain and spine injuries. J Intensive Care Med 2017; 34: 104-108.
Kurtz P, Fitts V, Sumer Z, et al. How does care differ for neurological patients admitted to a neurocritical care unit versus a general ICU? Neurocrit Care 2011; 15: 477-480.
Ovbiagele B, Saver JL. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis 2010; 29: 50-56.

Auteurs

M N Ungerer (MN)

Department of Neurology, University Hospital Heidelberg, Heidelberg.

P Ringleb (P)

Department of Neurology, University Hospital Heidelberg, Heidelberg.

B Reuter (B)

Helios Klinik Müllheim, Müllheim.

C Stock (C)

Institute of Medical Biometry and Informatics (IMBI), University of Heidelberg, Heidelberg.

F Ippen (F)

Department of Neurology, University Hospital Heidelberg, Heidelberg.

S Hyrenbach (S)

Qualitätssicherung im Gesundheitswesen Baden-Wuerttemberg (GeQiK Baden-Wuerttemberg), Stuttgart.

I Bruder (I)

Qualitätssicherung im Gesundheitswesen Baden-Wuerttemberg (GeQiK Baden-Wuerttemberg), Stuttgart.

P Martus (P)

Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany.

C Gumbinger (C)

Department of Neurology, University Hospital Heidelberg, Heidelberg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH